x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

AI For Pharma Growth

Dr Andree Bates

AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets to

technology entrepreneurship

All Episodes

29:20

E114 | The Next Evolution In Foundational Data Set...

AI For Pharma Growth ·

2024/05/21

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Philipp Lorenz, Chief Technology Officer of Basecamp Research. Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. They match and refine novel proteins for your exact industrial or therapeutic and diagnostic applications. In this episode you will learn: How Basecamp collected diverse biological sequence data How they partner with Nature Parks across five continents Why

en

26:59

E113 | Using AI To Uncover Legal And Regulatory Risks

AI For Pharma Growth ·

2024/05/14

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Matt Van Itallie, Founder and CEO of Sema. Sema is a software company that is squarely focused on understanding and improving tech. They build tools that bring technologists and non-technologists together. They’ve successfully managed the risks of Gen AI whilst capturing the benefits in the software development life cycle. The rapid advancement of Gen AI has regulators around the world reaching to understand, control and

en

41:11

E112 | Game On For Blockbusters, Novel MOAs, And...

AI For Pharma Growth ·

2024/05/07

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Ben Weintraub, the President of InThought Research and Doug Foster, Creator of the inVision software. inThought Research is a leading pharmaceutical and life science consulting firm providing analytical, forecasting, and competitive intelligence services to support strategic and tactical decisions of biopharmaceutical and financial firms. inVision is aimed at offering clients a streamlined interface for their business

en

27:10

E111 | The role of AI to create access to better...

AI For Pharma Growth ·

2024/04/30

Today Dr Andree Bates talks to Patricia Gall, Founder and CEO of MindSpark 360, about the organisation's pivotal role in advancing mental health innovation. MindSpark 360 operates as a structured programme, fostering open communication among all stakeholders in the mental health sector. Whether collaborating with corporations prioritising employee well-being or partnering with organisations driving new technologies and treatments for patients, MindSpark360 aims to facilitate sustainable

en

28:37

E110 | How Pharmacies can Leverage AI for Improved...

AI For Pharma Growth ·

2024/04/23

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eunice Wu, Co-Founder and CEO of Asepha. Asepha helps Pharmacies to work efficiently and faster through specific and intelligent tests on their AI models. Eunice explains the potential of AI in revolutionising pharmacy operations and patient care, particularly through improved speed and accuracy in repetitive tasks. Eunice points out the value of context in AI produced results and the bridge between current and evolving models

en

31:21

E109 | How AI is Enhancing HTA in Precision Oncology

AI For Pharma Growth ·

2024/04/16

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by haemato-oncologist Niamh Boyle, who works in the Health Economic Evaluation of Precision Medicine in Cancer research project, University of South Wales. Andree and Niamh discuss the use of AI in research methodologies and processes related to precision oncology. They also talk about how Health Technology Appraisal (HTA) bodies, such as the National Institute for Health and Care Excellence (NICE) implement and analyse AI in

en

23:19

E108 | Using AI to Assess Brain Health more...

AI For Pharma Growth ·

2024/04/09

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Liam Kaufman, Vice President of Cambridge Cognition. Andree and Liam talk about the use of AI during Central Nervous System (CNS) clinical research trials. They delve into how brain health and neural pathways can be explored and analysed, solely with the use of modern scientific technology. Cambridge Cognition’s work has been pivotal in CNS examination and treatment. Liam explains how far investigative methods in this field

en

27:22

E107 | Navigating Governance, Risk, and the AI Landscape

AI For Pharma Growth ·

2024/04/02

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Henz, Head of Governance Risk and Compliance at Primetals Technologies USA. In this episode, Andree and Patrick discuss the relevance and implementation of AI in compliance and risk. They explore the ethics and complexities of this practice by individuals and big corporations, as well as the responsibilities of those using generative AI, which is becoming increasingly autonomous. Addressing the key issues of machine

en

29:11

E106 | How AI is preventing maternal and fetal death...

AI For Pharma Growth ·

2024/03/27

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr Michelle Oyen, Associate Professor of Biomedical Engineering at Washington University in St.Louis. Michelle discusses the use and importance of AI in the field of maternal and fetal health. When an unexpected source changes Michelle’s career trajectory, she used her engineering background to research computational models to gather information related to pregnancy and childbirth. Michelle and her team have looked into all

en

44:43

E105 | Are we already at the point of human–computer...

AI For Pharma Growth ·

2024/03/20

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Hon Weng Chong, M.D., the founder of Cortical Labs. They discuss the inception of Cortical Labs and how the company is responsible for the creation of DishBrain, a powerful computational neuron system using human brain cells. Eventually, this cellular neuron system became so adaptive and responsive, it learned how to play the classic video game Pong. Beginning with the use of mouse brain cells, the development and implementation

en

28:05

E104 | How pharma can use AI for content compliance...

AI For Pharma Growth ·

2024/03/13

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Glinski and Ryan Brotman, the co-founders of Composehealth.ai. They discuss the use of artificial intelligence to automate the creation of an accurate content compliance review process, ready for use by individuals and businesses. Compose Health is an AI platform that gives its users a precise method of drafting and generating pharma content that is suitable for mandatory compliance laws. Their platform facilitates the

en

29:30

E103 | Using AI for cutting IND application time

AI For Pharma Growth ·

2024/03/06

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Ari Caroline, CEO of Weave Bio, to discuss how the company is using artificial intelligence to streamline the IND application process for new therapeutics. Weave Bio has developed an AI-powered platform that aims to cut the typical four month IND drafting time in half by automatically generating initial drafts of IND applications using supporting data and reports provided by users. The platform also helps organise data rooms,

en

27:24

E102 | How AI is being leveraged for addiction

AI For Pharma Growth ·

2024/02/28

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Manny Nsien, MHA the CEO of Ripple Ranch, an addiction treatment centre located in Texas. They talk about how artificial intelligence can be leveraged to more precisely diagnose those suffering from addiction earlier by analysing various streams of patient data, including information from medical records, wearable devices, genetics testing, and more. Additionally, they discuss how AI is being applied to personalise addiction

en

28:51

E101 | Marketing in the Age of AI

AI For Pharma Growth ·

2024/02/21

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Emanuel Rose to talk about Authentic Marketing in the Age of AI. You will learn how 51% of marketers are now using AI and various ways it's being used, including for copywriting, creative support, and data analysis. Emanuel discusses using AI in marketing while maintaining authenticity and emphasising brand voice, content calendars, and human input. Common mistakes like overreliance on AI without editing are covered. The

en

37:34

E100 | How Pharma can manage risk with cybersecurity...

AI For Pharma Growth ·

2024/02/14

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Greg Woolf of AI Think Tank to discuss managing cybersecurity risks with AI in the pharmaceutical industry. Greg draws from his experience launching AI companies to discuss the growing $10 trillion cybercrime industry. He addressed threats facing healthcare like ransomware and identity theft exploiting medical data breaches. Greg also covers challenges of reliability, bias and other risks with AI systems. However, he believes AI

en

37:30

E99 | How to use AI to connect meaningfully with...

AI For Pharma Growth ·

2024/02/07

In this episode of AI For Pharma Growth, Dr Andree Bates discusses SQREEM Technologies with Ian Chapman-Banks. SQREEM uses AI to analyse digital behaviours of healthcare professionals, helping pharmaceutical companies better engage this audience. SQREEM has developed advanced algorithms and one of the largest datasets on probabilistic healthcare professional profiles globally. The discussion provides insights into how SQREEM personalised marketing and ad targeting for professional segments. It

en

01:11:34

E98 | How to Use Generative AI models effectively for...

AI For Pharma Growth ·

2024/01/31

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jonathan Green who is an expert at using artificial intelligence tools to accelerate online business. He is the Best Selling Author of chat GPT Profits, and has a mailing list of over 100,000 subscribers. They talk about how generative AI is revolutionising digital marketing and how it can be used for tasks like content creation, data analysis, and customer engagement. Jonathan discusses how he uses AI tools like chatGPT,

en

44:10

E97 | Predictions about the future of Tech

AI For Pharma Growth ·

2024/01/24

In this episode of AI For Pharma Growth, host Dr Andree Bates interviews Sani Abdul-Jabbar, CEO of VezTek USA, a technology consulting firm. He has over 20 years of experience helping startups bring emerging technologies like AI and blockchain to market faster. He discusses his background and how VezTek supports clients. Sani also shares his insights on recent advancements in machine learning and blockchain, as well as predictions for industries like healthcare, fintech and beyond. In this

en

38:14

E96 | How Generative AI and Web3.0 are...

AI For Pharma Growth ·

2024/01/17

In this episode of AI For Pharma Growth, host Dr Andree Bates talks with Eric McHugh, president of SHOPX, to discuss opportunities at the intersection of generative AI and web3 for pharmaceutical companies. Eric explains how blockchain technologies like non-fungible tokens (NFTs) can help authenticate drugs and medical records to prevent counterfeiting. He also explores how patient data on the blockchain could help AI systems identify new treatment patterns and target drug development. Eric shares

en

41:30

E95 | How pharma R&D can use AI to accelerate...

AI For Pharma Growth ·

2024/01/10

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Casper Wilstrup, founder and CEO of Abzu. They discuss how Abzu's QLattice Explainable AI algorithm can be used to accelerate disease understanding, drug design, and insights in pharma R&D. Casper explains how the QLattice generates hypotheses to explain phenomena using symbolic AI without requiring large datasets. They explore applications in areas like biomarkers, RNA therapeutics, and reducing drug development timelines

en

196 results

Similar Podcasts

Lead With AI

Tamara Nall

Linux in the Ham Shack

Black Sparrow Media

Data Engineering Podcast

Tobias Macey

Eye On A.I.

Craig S. Smith

Reflections

Livewire Labs